BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 21354545)

  • 1. [Response to treatment with oral alitretinoin in patients with chronic hand eczema that is refractory to treatment with potent topical corticosteroids: experience in 15 patients].
    Aguayo-Leiva IR; Urrutia S; Jaén-Olasolo P
    Actas Dermosifiliogr; 2011 Oct; 102(8):616-22. PubMed ID: 21354545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial.
    Ruzicka T; Lynde CW; Jemec GB; Diepgen T; Berth-Jones J; Coenraads PJ; Kaszuba A; Bissonnette R; Varjonen E; Holló P; Cambazard F; Lahfa M; Elsner P; Nyberg F; Svensson A; Brown TC; Harsch M; Maares J
    Br J Dermatol; 2008 Apr; 158(4):808-17. PubMed ID: 18294310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of alitretinoin (BAL4079) in the treatment of severe chronic hand eczema refractory to potent topical corticosteroid therapy.
    Fowler JF; Graff O; Hamedani AG
    J Drugs Dermatol; 2014 Oct; 13(10):1198-204. PubMed ID: 25607554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral alitretinoin (9-cis-retinoic acid) therapy for chronic hand dermatitis in patients refractory to standard therapy: results of a randomized, double-blind, placebo-controlled, multicenter trial.
    Ruzicka T; Larsen FG; Galewicz D; Horváth A; Coenraads PJ; Thestrup-Pedersen K; Ortonne JP; Zouboulis CC; Harsch M; Brown TC; Zultak M
    Arch Dermatol; 2004 Dec; 140(12):1453-9. PubMed ID: 15611422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of alitretinoin on quality of life of patients having chronic hand eczema: an observational study.
    Gola M; D'Erme AM; Milanesi N; Marmugi L
    Dermatitis; 2013; 24(4):166-9. PubMed ID: 23857016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation and assessment of the therapeutic efficacy of alitretinoin in a group of patients with chronic hand eczema refractory to topical steroid therapy.
    Gola M; Milanesi N; D'Erme AM
    G Ital Dermatol Venereol; 2014 Aug; 149(4):435-9. PubMed ID: 25068232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alitretinoin: A Review in Severe Chronic Hand Eczema.
    Blair HA; Scott LJ
    Drugs; 2016 Sep; 76(13):1271-1279. PubMed ID: 27438290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An open-label study assessing the safety and efficacy of alitretinoin in patients with severe chronic hand eczema unresponsive to topical corticosteroids.
    Dirschka T; Reich K; Bissonnette R; Maares J; Brown T; Diepgen TL
    Clin Exp Dermatol; 2011 Mar; 36(2):149-54. PubMed ID: 21070335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful retreatment with alitretinoin in patients with relapsed chronic hand eczema.
    Bissonnette R; Worm M; Gerlach B; Guenther L; Cambazard F; Ruzicka T; Maares J; Brown TC
    Br J Dermatol; 2010 Feb; 162(2):420-6. PubMed ID: 19906075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral Alitretinoin in the Treatment of Severe Refractory Chronic Hand Eczema in the Spanish National Health System: Description and Analysis of Current Clinical Practice.
    Urrutia S; Roustan G; Plazas MJ; Armengol S; Paz S; Lizan L
    Actas Dermosifiliogr; 2016 Mar; 107(2):142-8. PubMed ID: 26363930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alitretinoin for the treatment of severe chronic hand eczema.
    Paulden M; Rodgers M; Griffin S; Slack R; Duffy S; Ingram JR; Woolacott N; Sculpher M
    Health Technol Assess; 2010 May; 14 Suppl 1():39-46. PubMed ID: 20507802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended treatment with oral alitretinoin for patients with chronic hand eczema not fully responding to initial treatment.
    Lynde C; Cambazard F; Ruzicka T; Sebastian M; Brown TC; Maares J
    Clin Exp Dermatol; 2012 Oct; 37(7):712-7. PubMed ID: 22731739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of alitretinoin for severe refractory chronic hand eczema: Clinical studies and postmarketing surveillance.
    Morris M; Schifano L; Fong R; Graff O
    J Dermatolog Treat; 2016; 27(1):54-8. PubMed ID: 25886084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of chronic hand eczema with oral 9-cis-retinoic acid.
    Bollag W; Ott F
    Dermatology; 1999; 199(4):308-12. PubMed ID: 10640839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Everyday clinical experience of alitretinoin in the treatment of severe chronic hand eczema: seven case studies.
    English J; Graham-Brown R; de Sica Chapman A; Alexandroff AB
    Clin Exp Dermatol; 2011 Mar; 36 Suppl():1-2. PubMed ID: 21309810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Off-label use of alitretinoin].
    Fritz K; Tiplica GS; Salavastru C; Onder M
    Hautarzt; 2013 Oct; 64(10):748-51. PubMed ID: 24150823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics, efficacy and safety of alitretinoin in moderate or severe chronic hand eczema.
    Schmitt-Hoffmann AH; Roos B; Sauer J; Spickermann J; Stoeckel K; Edwards D; van de Wetering J; Coenraads PJ; Maares J
    Clin Exp Dermatol; 2011 Apr; 36 Suppl 2():29-34. PubMed ID: 21443602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral alitretinoin in chronic refractory hand eczema: a "real life" case-series of 12 patients.
    Kubica E; Ezzedine K; Lalanne N; Dartial Y; Taieb A; Milpied B
    Eur J Dermatol; 2011; 21(3):454-6. PubMed ID: 21680291
    [No Abstract]   [Full Text] [Related]  

  • 19. Alitretinoin: in severe chronic hand eczema.
    Garnock-Jones KP; Perry CM
    Drugs; 2009 Aug; 69(12):1625-34. PubMed ID: 19678713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact on quality of life of alitretinoin in severe chronic hand eczema: FUGETTA real-world study.
    Augustin M; Thaçi D; Kamps A
    J Dtsch Dermatol Ges; 2016 Dec; 14(12):1261-1270. PubMed ID: 27992140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.